Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
BMC Psychiatry
Papers 3717
1 page of 372 pages (3,717 results)
Published on Feb 19, 2019in BMC Psychiatry 2.67
Andrea Galova (Geneva College), Patricia Berney2
Estimated H-index: 2
(Geneva College)
+ 2 AuthorsMarie Besson11
Estimated H-index: 11
(Geneva College)
Background Rebound cholinergic syndrome is a rare, but well known unwanted phenomenon occurring after abrupt clozapine discontinuation. There have been previous reported cases of cholinergic rebound in the literature; however, these reports described cholinergic rebound following cessation of high doses of clozapine in patients diagnosed with schizophrenia. Here, we report a case of rebound cholinergic syndrome and catatonia in a male patient three days after abrupt discontinuation of 50 mg of c...
Published on Dec 1, 2019in BMC Psychiatry 2.67
Oksoo Kim11
Estimated H-index: 11
(Ewha Womans University),
Yanghee Pang (Ewha Womans University), Jung-Hee Kim2
Estimated H-index: 2
(Catholic University of Korea)
Virtual Reality (VR) is increasingly used in health-related fields and interventions using VR have the potential to be powerful tools in patient management. The aim of this study was to synthesize the effects of VR interventions for people with mild cognitive impairment (MCI) or dementia. Electronic databases were searched to identify studies that used an experimental design to investigate VR intervention outcomes for patients with MCI or dementia. Studies were excluded if the intervention did n...
Published on Dec 1, 2019in BMC Psychiatry 2.67
Anat Gesser-Edelsburg9
Estimated H-index: 9
(University of Haifa),
Rasha Hamade Boukai (University of Haifa)
There has been a steady rise in the use of medication by Israeli school children to treat ADHD, partly due to what seems like school teachers’ and counselors’ tendency to express positive attitudes towards its use. Therfore it is important to examine the involvement of the school teachers and counselors in the parents’ decision-making about giving their children medication. This study used a qualitative constructivist research method of semi-structured interviews. It included individual intervie...
Published on Apr 16, 2019in BMC Psychiatry 2.67
Sally Mustafa5
Estimated H-index: 5
(Douglas Mental Health University Institute),
Joanna Bougie1
Estimated H-index: 1
+ 4 AuthorsAshok Malla56
Estimated H-index: 56
(McGill University)
Background With previously established efficacy of aripiprazole once-monthly injectable formulation (AOM) in pre-registration randomized controlled trials, the current study was designed to evaluate its effectiveness in patients treated for schizophrenia in regular clinical settings in Canada.
Published in BMC Psychiatry 2.67
D.H. Jaffe , Benoit Rive (Janssen-Cilag), T. Denee (Janssen-Cilag)
A patient is considered to suffer from treatment resistant depression (TRD) when consecutive treatment with two products of different pharmacological classes, used for a sufficient length of time at an adequate dose, fail to induce a clinically meaningful effect (inadequate response). The primary aim of the current study was to examine the humanistic and economic burden of TRD in five European countries, France, Germany, Italy, Spain and the United Kingdom, by comparing with non-treatment resist...
Published on Feb 4, 2019in BMC Psychiatry 2.67
Charlie Albert Smith (UCL: University College London), Ann McNeill56
Estimated H-index: 56
('KCL': King's College London)
+ 1 AuthorsLion Shahab23
Estimated H-index: 23
(UCL: University College London)
Smoking has played a significant role in the historical culture of mental healthcare settings. Mental health professionals (MHPs) often hold dismissive attitudes regarding the importance of smoking cessation in the context of mental healthcare. In 2007, English mental health inpatient buildings were required by law to become smoke-free, and healthcare trusts have more recently begun to implement comprehensive policies (i.e. smoke-free grounds and buildings) and staff training in response to nati...
Published on Mar 1, 2019in BMC Psychiatry 2.67
Tamirat Tesfaye Dasa1
Estimated H-index: 1
Aklilu Abrham Roba1
Estimated H-index: 1
(Haramaya University)
+ 8 AuthorsMahantash Naganuri1
Estimated H-index: 1
Background Depression among tuberculosis patients, especially in settings with low economic status is common. Screening for depression in all levels of health facilities can identify patients who need support and treatment for depression.
Published on Dec 1, 2019in BMC Psychiatry 2.67
Sigmund Karterud27
Estimated H-index: 27
Elfrida Hartveit Kvarstein6
Estimated H-index: 6
(Oslo University Hospital)
In this correspondence we correct some misleading information about mentalization-based treatment in Oslo, Norway.
Published on Dec 1, 2019in BMC Psychiatry 2.67
Richard C. Oude Voshaar30
Estimated H-index: 30
(UMCG: University Medical Center Groningen),
Ton Dhondt1
Estimated H-index: 1
+ 11 AuthorsRadboud M. Marijnissen6
Estimated H-index: 6
Background Affective disorders, encompassing depressive-, anxiety-, and somatic symptom disorders, are the most prevalent mental disorders in later life. Treatment protocols and guidelines largely rely on evidence from RCTs conducted in younger age samples and ignore comorbidity between these disorders. Moreover, studies in geriatric psychiatry are often limited to the “younger old” and rarely include the most frail. Therefore, the effectiveness of treatment in routine clinical care for older pa...
Published on Dec 1, 2019in BMC Psychiatry 2.67
Shigenobu Kanba54
Estimated H-index: 54
(Kyushu University),
Mitsukuni Murasaki12
Estimated H-index: 12
+ 5 AuthorsShinya Kamei1
Estimated H-index: 1
In an 8-week, randomized, placebo-controlled, double-blind study, an extended-release formulation of quetiapine, quetiapine XR, demonstrated efficacy and safety in Japanese patients with bipolar depression. Bipolar disorder is a chronic disease requiring continuous treatment. This was a long-term (52-week), open-label, non-controlled extension study to evaluate the long-term safety and efficacy of quetiapine XR in Japanese patients with bipolar depression who had previously completed the initial...